Syros CEO, chief scientist out as company cuts staff, programs

The founding CEO of Syros Pharmaceuticals Inc. is departing after 11 years as the company lays off about one-third of its workforce and cuts drug programs.

Making waves: Indoor/outdoor concert venue planned for downtown Wichita

Impact Axe bringing beer, recreational games to Rocklin

BEST IN FINANCE: Meet the 24 executives who serve as financial stewards of their organizations

Businessman eyes big retail potential in Chatham near VinFast site

Colliers acquires majority stake in Phoenix real estate management firm

Advisory panel recommends Oregon regulators reject CareOregon-SCAN merger

D.C.’s Vegetable and Butcher receiving nearly $1M in incentives to relocate to Maryland

Incoming Houston Association of Realtors Chair Cathy Treviño on what to expect in 2023

Syros CEO, chief scientist out as company cuts staff, programs

Previous Wisconsin startup wins contracts at 'Shark-Tank'-like community health competition

Next Syneos Health replaces CEO with life sciences veteran Colin Shannon days after $7B deal closes

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

General Electric will spin off GE HealthCare in January 2023, unveils board

Four cryptocurrency ICOs asked to prove why Colorado shouldn’t stop them

CRE firm moves Bham office from downtown to over the mountain

NorthPoint completes night-and-day HQ remake of former Cerner Oaks Campus [PHOTOS]

Madison Avenue office building is 100% leased after $24M renovation

Portion of Tyrone Square Mall sells for $37.8 million

MENU

FirstStar Group

More Stories

Banking & Finance Roundup: Insigneo secures $100M investment

Previous Wisconsin startup wins contracts at 'Shark-Tank'-like community health competition

Next Syneos Health replaces CEO with life sciences veteran Colin Shannon days after $7B deal closes

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories